clioquinol has been researched along with Invasiveness, Neoplasm in 1 studies
Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitrović, A | 1 |
| Kljun, J | 1 |
| Sosič, I | 1 |
| Gobec, S | 1 |
| Turel, I | 1 |
| Kos, J | 1 |
1 other study available for clioquinol and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Clioquinol-ruthenium complex impairs tumour cell invasion by inhibiting cathepsin B activity.
Topics: Antineoplastic Agents; Cathepsin B; Cell Line, Tumor; Clioquinol; Cymenes; Enzyme Inhibitors; Humans | 2016 |